Xiulian Sun PH.D.

Industry Honorary Professor 企业特聘教授


孙秀莲博士是美国药典委员会AAV基因治疗专家小组成员,首届泰山学者特聘专家,苏州金鸡湖科技领军人才。也是,四项国家自然科学基金项目负责人、先后获得中华人民共和国科技进步二等奖 、国际脑研究协会(IBRO)会议奖 、加拿大生命科学院Age Plus等奖项。在细胞与基因药物开发、GMP规模化生产等,都有着丰富的研究经验。

Dr. Xiulian Sun
President and CTO of Ubrigene

Dr. Xiulian Sun received her PhD in neuroscience from University of British Columbia (UBC), Canada, and received Bachelor & Master degree of Medicine from Nankai University,China.
She has been engaged in Biopharmaceutical Science for more than 16 years. In 2012, she co-founded VIGENE as CTO, and in 2015, she co-founded Ubrigene (formerly known as Yiming Cell), as the president and CTO.
Dr. Xiulian Sun is a member of AAV Expert Panel of US Pharmacopeia Convention (USP), the First Distinguished Taishan Scholar and the Jinji Lake leading talent in science & technology of Suzhou for her contribution to scientific and technological innovations.
She is in charge of four China National Natural Science Foundation projects, and won the Second Prize of Scientific and Technological Progress of China. She also won the Session Award of International Brain Research Association (IBRO) and Age Plus of Canadian Academy of Life Sciences, etc. In addition, she has rich research experience in cell and gene drug development and GMP large-scale production.
Xiulian Sun